RBM3 and ovarian carcinoma: In this study, we sought to address this gap by analyzing RBM3 expression using immunohistochemistry on a well-characterized, single-institution cohort of 183 epithelial ovarian cancer cases, applying a statistically validated nuclear scoring algorithm to stratify RBM3 expression levels.